Center-Authored Papers

Filters: Author is Blazar, Bruce R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Brunstein CG, Petersdorf EW, Defor TE, Noreen H, Maurer D, Macmillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR et al..  2015.  Impact of Allele Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
C
Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB et al..  2016.  The Biology of Chronic Graft-Versus-Host Disease: a Task Force Report From the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
D
Du J, Flynn R, Paz K, Ren H-G, Ogata Y, Zhang Q, Gafken PR, Storer BE, Roy NH, Burkhardt JK et al..  2018.  Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.. Blood. 131(15):1743-1754. Abstract
F
Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L et al..  2015.  Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.. Science translational medicine. 7(315):315ra191. Abstract
Furlan SN, Watkins B, Tkachev V, Cooley S, Panoskaltsis-Mortari A, Betz K, Brown M, Hunt DJ, Schell JB, Zeleski K et al..  2016.  Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and man.. Blood. Abstract
H
Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, Kamdar M, Kanate AS, Saad A, Mehta A et al..  2017.  PD-1 blockade for relapsed lymphoma post allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.. Blood. Abstract
Hippen KL, Watkins B, Tkachev V, Lemire AM, Lehnen C, Riddle MJ, Singh K, Panoskaltsis-Mortari A, Vanhove B, Tolar J et al..  2016.  Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease.. Transplantation. 100(12):2630-2639. Abstract
Hippen KL, Watkins B, Tkachev V, Lemire AM, Lehnen C, Riddle MJ, Singh K, Panoskaltsis-Mortari A, Vanhove B, Tolar J et al..  2016.  Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).. Transplantation. Abstract
K
Kaliyaperumal S, Watkins B, Sharma P, Furlan S, Ramakrishnan S, Giver C, Garcia A, Courtney C, Knight H, Strobert E et al..  2014.  CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.. Blood. 123(12):1967-9.
Kean LS, Turka LA, Blazar BR.  2017.  Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.. Immunological reviews. 276(1):192-212. Abstract
L
Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, Choi SW, Zhang P, Greenson JK, Liu C et al..  2016.  Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.. JCI insight. 1(6) Abstract
M
Macmillan ML, Robin M, Harris AC, Defor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JLM, Jones R et al..  2015.  A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):761-7. Abstract
Miller JS, Warren EH, van den Brink MRM, Ritz J, Shlomchik WD, Murphy WJ, Barrett JA, Kolb HJ, Giralt S, Bishop MR et al..  2010.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: . Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):565-86. Abstract
O
Osborn MJ, Webber BR, Knipping F, Lonetree C-L, Tennis N, DeFeo AP, McElroy AN, Starker CG, Lee C, Gabriel R et al..  2015.  Evaluation of TCR Gene Editing achieved by TALENs, CRISPR/Cas9 and megaTAL nucleases.. Molecular therapy : the journal of the American Society of Gene Therapy. Abstract
S
Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN et al..  2016.  Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.. The Journal of clinical investigation. 126(7):2642-60. Abstract
Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, Stempora L, Horan JT, Langston A, Qayed M et al..  2015.  CMV reactivation drives post-transplant T cell reconstitution and results in defects in the underlying TCRβ repertoire.. Blood. Abstract
T
Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp WD et al..  2011.  Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1193-8. Abstract
Z
Zheng HB, Watkins B, Tkachev V, Yu S, Tran D, Furlan S, Zeleski K, Singh K, Hamby K, Hotchkiss C et al..  2016.  The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism But With A Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Abstract